These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 20415475)

  • 1. Challenges for molecular magnetic resonance imaging.
    Terreno E; Castelli DD; Viale A; Aime S
    Chem Rev; 2010 May; 110(5):3019-42. PubMed ID: 20415475
    [No Abstract]   [Full Text] [Related]  

  • 2. Linear assemblies of magnetic nanoparticles as MRI contrast agents.
    Corr SA; Byrne SJ; Tekoriute R; Meledandri CJ; Brougham DF; Lynch M; Kerskens C; O'Dwyer L; Gun'ko YK
    J Am Chem Soc; 2008 Apr; 130(13):4214-5. PubMed ID: 18331033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and magnetic resonance imaging: The value of immunoliposomes.
    Kozlowska D; Foran P; MacMahon P; Shelly MJ; Eustace S; O'Kennedy R
    Adv Drug Deliv Rev; 2009 Dec; 61(15):1402-11. PubMed ID: 19796661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards multimodal nanoparticle labels for molecular imaging of biological processes.
    Babinec P; Babincová M
    Med Hypotheses; 2007; 69(3):703-4. PubMed ID: 17329036
    [No Abstract]   [Full Text] [Related]  

  • 5. Magneto-optical FeGa2O4 nanoparticles as dual-modality high contrast efficacy T2 imaging and cathodoluminescent agents.
    Huang CC; Su CH; Liao MY; Yeh CS
    Phys Chem Chem Phys; 2009 Aug; 11(30):6331-4. PubMed ID: 19809662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superparamagnetic iron oxide nanoparticle-embedded encapsulated microbubbles as dual contrast agents of magnetic resonance and ultrasound imaging.
    Yang F; Li Y; Chen Z; Zhang Y; Wu J; Gu N
    Biomaterials; 2009 Aug; 30(23-24):3882-90. PubMed ID: 19395082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging concepts in molecular MRI.
    Sosnovik DE; Weissleder R
    Curr Opin Biotechnol; 2007 Feb; 18(1):4-10. PubMed ID: 17126545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relaxometric and magnetic characterization of ultrasmall iron oxide nanoparticles with high magnetization. Evaluation as potential T1 magnetic resonance imaging contrast agents for molecular imaging.
    Taboada E; Rodríguez E; Roig A; Oró J; Roch A; Muller RN
    Langmuir; 2007 Apr; 23(8):4583-8. PubMed ID: 17355158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmonic magnetic nanostructure for bimodal imaging and photonic-based therapy of cancer cells.
    Lim YT; Cho MY; Kim JK; Hwangbo S; Chung BH
    Chembiochem; 2007 Dec; 8(18):2204-9. PubMed ID: 17957817
    [No Abstract]   [Full Text] [Related]  

  • 10. Bis-phosphonates-ultra small superparamagnetic iron oxide nanoparticles: a platform towards diagnosis and therapy.
    Lalatonne Y; Paris C; Serfaty JM; Weinmann P; Lecouvey M; Motte L
    Chem Commun (Camb); 2008 Jun; (22):2553-5. PubMed ID: 18506241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical enhancements of MRI contrast and hyperthermic effects by dopant-controlled magnetic nanoparticles.
    Jang JT; Nah H; Lee JH; Moon SH; Kim MG; Cheon J
    Angew Chem Int Ed Engl; 2009; 48(7):1234-8. PubMed ID: 19137514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications.
    Aime S; Castelli DD; Crich SG; Gianolio E; Terreno E
    Acc Chem Res; 2009 Jul; 42(7):822-31. PubMed ID: 19534516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smart "turn-on" magnetic resonance contrast agents based on aptamer-functionalized superparamagnetic iron oxide nanoparticles.
    Yigit MV; Mazumdar D; Kim HK; Lee JH; Odintsov B; Lu Y
    Chembiochem; 2007 Sep; 8(14):1675-8. PubMed ID: 17696177
    [No Abstract]   [Full Text] [Related]  

  • 14. Multifunctional nanoparticles displaying magnetization and near-IR absorption.
    Wang L; Bai J; Li Y; Huang Y
    Angew Chem Int Ed Engl; 2008; 47(13):2439-42. PubMed ID: 18278779
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experiment and analyse on the effect of magnetic nanoparticles upon relaxation time of proton in molecular recognition by MRI].
    Hu L; Song T; Yang W; Wang M; Zhang F; Tao C
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Jun; 24(3):590-4, 614. PubMed ID: 17713268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical application of functionalized magnetic nanoparticles.
    Ito A; Shinkai M; Honda H; Kobayashi T
    J Biosci Bioeng; 2005 Jul; 100(1):1-11. PubMed ID: 16233845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface functionalization of single superparamagnetic iron oxide nanoparticles for targeted magnetic resonance imaging.
    Amstad E; Zurcher S; Mashaghi A; Wong JY; Textor M; Reimhult E
    Small; 2009 Jun; 5(11):1334-42. PubMed ID: 19242944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lanthanides in magnetic resonance imaging.
    Bottrill M; Kwok L; Long NJ
    Chem Soc Rev; 2006 Jun; 35(6):557-71. PubMed ID: 16729149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled clustering of superparamagnetic nanoparticles using block copolymers: design of new contrast agents for magnetic resonance imaging.
    Berret JF; Schonbeck N; Gazeau F; El Kharrat D; Sandre O; Vacher A; Airiau M
    J Am Chem Soc; 2006 Feb; 128(5):1755-61. PubMed ID: 16448152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paramagnetic ultrasmall gadolinium oxide nanoparticles as advanced T1 MRI contrast agent: account for large longitudinal relaxivity, optimal particle diameter, and in vivo T1 MR images.
    Park JY; Baek MJ; Choi ES; Woo S; Kim JH; Kim TJ; Jung JC; Chae KS; Chang Y; Lee GH
    ACS Nano; 2009 Nov; 3(11):3663-9. PubMed ID: 19835389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.